Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer-Reference-Cited by-同舟云学术

Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer

Published:2020-03-03 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Yunxia¹,Huang Jianfeng¹,Zou Qinzhou¹,Che Jun¹,Yang Kaihua¹,Fan Qiang¹,Qian Danqi¹,Wu Jia¹,Bao Erwen¹,Song Lele²,Zhang Fuzheng¹

Affiliation:

1. Department of Radiotherapy, The Affiliated Hospital of Jiangnan University, Binhu, Wuxi, Jiangsu 214062, P.R. China

2. Department of Radiotherapy, The Eighth Medical Center of The Chinese People's Liberation Army General Hospital, Haidian, Beijing 100091, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect Evaluation of Bronchial Artery Embolization for Hemoptysis of Lung Cancer and Changes in Serum Tumor Markers and miR-34 Levels;Contrast Media & Molecular Imaging;2022-08-16

2. Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database;BioMed Research International;2022-06-24

3. Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors;Biology;2022-04-13

4. DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma;Journal for ImmunoTherapy of Cancer;2022-03

5. Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma;Frontiers in Oncology;2022-01-21